Lifinity provides a telehealth platform for personalized NAD+ therapies delivered directly to your home. Connect with licensed medical providers for tailored treatment plans designed to enhance cellular energy, cognitive function, and overall vitality.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals experience declining energy levels, reduced cognitive function, and a general decrease in vitality as they age. Existing solutions often require in-person clinic visits, which can be inconvenient and time-consuming, limiting consistent access to supportive therapies.
Solution
Lifinity offers a telehealth platform that provides personalized NAD+ therapies delivered directly to patients' homes. The service connects users with licensed medical providers who create tailored treatment plans based on individual health assessments. This approach aims to enhance cellular energy production, improve cognitive sharpness, and restore overall vitality through convenient, at-home administration of NAD+ precursors. The platform facilitates a streamlined process from initial consultation to treatment delivery, ensuring accessibility and ease of use for individuals seeking to improve their well-being.
Target Audience
The primary target audience includes adults aged 35-55 experiencing fatigue, cognitive decline, or a general lack of vitality who are seeking convenient, at-home health solutions.
Features
- Telehealth platform connecting patients with licensed medical providers for personalized NAD+ therapy plans.
- At-home delivery of NAD+ precursor treatments, including capsules and injections.
- Online quiz and medical provider evaluation to determine treatment suitability.
- Focus on enhancing cellular energy production, cognitive function, and vitality.
- Support for memory, mood, and processing speed.
- Discreet packaging and delivery of all necessary treatment components.
- Access to a network of licensed medical professionals across all 50 states.